![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, July 14, 2021 8:47:42 AM
'Pisd', for contracts/revenues; so "manufacture"? or trial?, Labs losing my confidence atm... gl
I expect to leave my Medi shares to ride throughout the new management's international expansion and MediPharm Branded Product expansion which may take years.
It's a crap shoot to see if they can execute on the turn-around plan, or end up "a failed also ran" trading near $0, with a diluted O/S between 500,000,000 to 1,000,000,000?
The last MediPharm ER was a huge downer. I was hoping for $10M. Instead they posted $5.5M, a decline from $6.1.
I have no idea if MediPharm can successfully implement the new business plan. This morning's news is a step in the right direction. Let's see how they leverage it.
MediPharm is hoping for EU and South American cannabis growth. They need a lot of new medical customers ready to place orders and feed the supply chain to end users.
Therefore, MediPharm's focus is on the future. We need results now.
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM